Translational Lung Cancer Research

Article	Citations
Selpercatinib in patients with RET fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trial	115
Tackling the challenge of brain involvement in driver-negative non-small cell lung cancer	58
Towards a clinically applicable histomolecular classification of lung adenocarcinomas?	55
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel	53
Development of a haematological indices-based nomogram for prognostic prediction and immunotherapy response assessment in primary pulmonary lymphoepithelioma-like carcinoma patients	52
Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy	49
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer	47
Contribution of crosstalk of mesothelial and tumoral epithelial cells in pleural metastasis of lung cancer	44
Contrast-enhanced CT and PET-CT characteristics of primary tracheal lymphoepithelioma-like carcinoma: case series	41
Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung	39
Alectinib continuation beyond progression in ALK-positive non-small cell lung cancer with alectinib-refractory	36
Osimertinib as induction therapy for oligometastatic non-small cell lung cancer with EGFR mutation: a case report	35
Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302)	34
Supervision by an experienced surgeon can reduce the learning curve of uniportal thoracoscopic lobectomy	33
Sunvozertinib: shining light on lung cancer’s exon 20 fight	32
Novel LZTR1 germline mutation as a mechanism of resistance to osimertinib in EGFR-mutated lung adenocarcinoma: a case report	29
Learning from chronic disease screening success: developing efficient, convenient, and affordable lung cancer screening methods to achieve universal coverage	29
Cost-effectiveness analysis of anlotinib as a third-line or further treatment for advanced non-small cell lung cancer in China	28
Cerebrospinal fluid cytology for the diagnosis of lung cancer brain metastasis: a case report	28
Circulating mitochondrial DNA as a biomarker for lung cancer screening	27
Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer	27
Limited-anatomic resection for ground-glass like lung cancer—simplicity does not mean inefficacy	27
Real-time digital polymerase chain reaction (PCR) as a novel technology improves limit of detection for rare allele assays	25
High NHLRC2 expression is associated with shortened survival in lung adenocarcinoma	25
A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-cent	24

The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030	24
Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system	23
Surgical perception of lower tracheal or carinal resection	22
CLOCK’ing differences in DNA methylation signatures to understand the molecular etiology of lung cancer	21
Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist	21
Has programmed cell death ligand-1 MET an accomplice in non-small cell lung cancer?—a narrative review	21
Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer	21
Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer	21
One more piece to SOLIDify our knowledge on the impact of SARS-CoV-2 in patients with cancer	21
Pushing the boundaries of minimally invasive surgery	21
Utility and safety of sole electromagnetic navigation bronchoscopy under moderate sedation for lung cancer diagnosis	21
Pathological and imaging features of pulmonary invasive mucinous adenocarcinoma—a retrospective cohort study	21
Carinal resection and reconstruction with complete pulmonary parenchyma preservation: a single-institution analysis of 36 cases	20
Efficacy and safety of alectinib in ALK-positive non-small cell lung cancer and blood markers for prognosis and efficacy: a retrospective cohort study	19
Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review	19
Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma	19
Surgical mediastinal lymph node staging for non-small-cell lung carcinoma	19
A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes	18
Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study	18
Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1–N2 epidermal growth factor receptor mutant lung adenocarcinoma	18
Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question	18
Lobectomy with pulmonary artery angioplasty for lung cancer using video-assisted thoracic surgery versus open thoracotomy: a retrospective propensity matched analysis	18
Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon?	17
Augmented reality-assisted localization of solitary pulmonary nodules for precise sublobar lung resection: a preliminary study using an animal model	17
Efficacy of alectinib in lung adenocarcinoma patients with different anaplastic lymphoma kinase (ALK) rearrangements and co-existing alterations—a retrospective cohort study	17
PD-L1 expression in non-small cell lung carcinoma in Latin America: a systematic review and meta-analysis	17
Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients	17
The treatment of advanced non-small cell lung cancer harboring KRAS mutation: a new class of drugs for an old target—a narrative review	17
PFKP confers chemoresistance by upregulating ABCC2 transporter in non-small cell lung cancer	17
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistanc	17
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study	17
Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer	16
Prediction of future imagery of lung nodule as growth modeling with follow-up computed tomography scans using deep learning: a retrospective cohort study	16
A narrative review of deep learning applications in lung cancer research: from screening to prognostication	16
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma	16
Liquid biopsy in non-small cell lung cancer—current status and future outlook—a narrative review	16
Histopathologic pattern and molecular risk stratification are associated with prognosis in patients with stage IB lung adenocarcinoma	16
Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block	15
EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature	15
A multi-level investigation of the genetic relationship between gastroesophageal reflux disease and lung cancer	15
Comparison of perioperative outcomes among non-small cell lung cancer patients with neoadjuvant immune checkpoint inhibitor plus chemotherapy, EGFR-TKI, and chemotherapy alone: a real-world evidence s	15
The current state of carinal resection and role of minimally invasive techniques	15
Tremelimumab and durvalumab with chemotherapy in first-line treatment for metastatic non-small cell lung cancer: a US-based cost-effectiveness analysis	15
Impact of chronic obstructive pulmonary disease on lung cancer symptom burden: a population-based study in Ontario, Canada	15
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review	15
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report	15
Squamous-cell carcinoma of the recipient’s explanted lung	15
Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review	14
Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort stud	14
Recurrence prediction of lung adenocarcinoma using an immune gene expression and clinical data trained and validated support vector machine classifier	14

A nomogram for predicting invasiveness of lung adenocarcinoma manifesting as ground-glass nodules based on follow-up CT imaging	14
Pathological and radiological T descriptors in invasive lung adenocarcinoma: from correlations to prognostic significance	14
Adjuvant treatment for patients with incidentally resected limited disease small cell lung cancer—a retrospective study	14
Tract creation with a 25-gauge needle for convex endobronchial ultrasound-guided core biopsy in intrapulmonary lesions adjacent to bronchi: three case reports	14
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study	14
MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report	14
Exposure-lag response of surface net solar radiation on lung cancer incidence: a global time-series analysis	14
Navigation of video-assisted thoracoscopic surgery using electromagnetic versus CT-guided localization (NOVEL): a study protocol for comparing procedural success and complication rates in a prospectiv	14
Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients	14
Microbiota modulate lung squamous cell carcinoma lymph node metastasis through microbiota-geneset correlation network	14
Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-bas	14
Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment	14
Electromagnetic navigation bronchoscopy-guided preoperative lung nodule localization in video-assisted thoracic surgery (VATS): a learning curve analysis	14
Augmented reality navigation-guided intraoperative pulmonary nodule localization: a pilot study	14
Predictive biomarkers for immune checkpoint efficacy: is multi-omics breaking the deadlock?	14
“We need to work towards it, whatever it takes.”—participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders	14
End-to-side anastomosis in complex tracheal resection and reconstruction: a case series study	14
Fusion gene recurrence in non-small cell lung cancers and its association with cigarette smoke exposure	13
The incidence and risk factors of acute pain after preoperative needle localization of pulmonary nodules: a cross-sectional study	13
A random forest algorithm predicting model combining intraoperative frozen section analysis and clinical features guides surgical strategy for peripheral solitary pulmonary nodules	13
Perioperative and long-term outcomes of spontaneous ventilation video-assisted thoracoscopic surgery for non-small cell lung cancer	13
Cathepsin detection to identify malignant cells during robotic pulmonary resection	13
Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors	13
Patient-led advocacy in ALK-positive lung cancer	13
Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea	13
Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literature	13
Dielectric property measurements for the rapid differentiation of thoracic lymph nodes using XGBoost in patients with non-small cell lung cancer: a self-control clinical trial	13
Emerging and multifaceted role of neutrophils in lung cancer	13
A large-scale, multicentered trial evaluating the sensitivity and specificity of digital PCR versus ARMS-PCR for detecting ctDNA-based EGFR p.T790M in non-small-cell lung cancer patients	13
Comparison of lobectomy performed through Toumai® surgical robot and da Vinci surgical robot in early-stage non-small cell lung cancer: a retrospective study of early perioperative results	12
Can a dysfunctional T-cell gene signature predict nonresponse to PD-1 blockade in non-small cell lung cancer?	12
Adrenal crisis and acute exacerbation of interstitial lung disease after thymoma needle biopsy: a case report and literature review	12
Identification of PD-1 ligands: PD-L1 and PD-L2 on macrophages in lung cancer milieu by flow cytometry	12
Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer	12
Clinical and financial impact of immune checkpoint inhibitors following platinum chemotherapy in patients with advanced or metastatic non-small cell lung cancer: a nationwide population-based study	12
PTS is activated by ATF4 and promotes lung adenocarcinoma development via the Wnt pathway	12
Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer—a narrative review	12
The (un)lucky seven—how can we mitigate risk factors for postoperative pneumonia after lung resections?	12
Resected lung adenocarcinoma with lymph node metastasis: is ground glass opacity component a prognostic factor?	12
Prognostic value of L4 lymph node dissection during video-assisted thoracoscopic surgery in patients with left-sided non-small cell lung cancer: a single-center, retrospective cohort study	12
Role of CDK4/6 inhibitors in targeting Rb proficient small cell lung cancer	12
A pilot study of anlotinib with third-generation epidermal growth factor receptor tyrosine kinase inhibitors in untreated EGFR-mutant patients with advanced non-small cell lung cancer	12
Clinical insights: five-year follow-up of KEYNOTE-189 trial outcomes and more	12
Effect of family history of cancer on postoperative survival in patients with non-small cell lung cancer	12
Steerable guiding sheaths in peripheral bronchoscopy	12
Combinatorial therapy is a safe and durable treatment option in ALK-rearranged non-small cell lung cancer with an acquired MET exon 14 skipping mutation mediated resistance to alectinib: a case report	12
PD-L1 expression from surgically resected lung tumors predictive of early progression in patients previously treated with targeted therapy for initially unresectable non-small cell lung cancer	12
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature	11
A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer	11
Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review	11
Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients wit	11
Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer	11
Let-7b-3p inhibits tumor growth and metastasis by targeting the BRF2-mediated MAPK/ERK pathway in human lung adenocarcinoma	11
Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target	11
Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma	11
Menstrual factors, reproductive history, and risk of lung cancer: a multi-center population-based cohort study in Chinese females	11
The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastases	11
Enhancing the prediction of KRAS mutation status in Asian lung adenocarcinoma: a comprehensive approach combining clinical, dual-energy spectral computed tomography, and radiomics features	11
Integrated analysis reveals the microenvironment of non-small cell lung cancer and a macrophage-related prognostic model	11
Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis	11
Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer	11
CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer	11
Application of indocyanine green injection guided by electromagnetic navigation bronchoscopy in localization of pulmonary nodules	11
Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives	11
Fuel for thought: targeting metabolism in lung cancer	11
Successful long-term outcome of neoadjuvant sequential targeted therapy and chemotherapy for stage III non-small cell lung carcinoma: 10 case series	11
Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer	11
Adjuvant chemotherapy for completely resected IIA–IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice	10
Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma	10
Construction of a neutrophil extracellular trap formation-related gene model for predicting the survival of lung adenocarcinoma patients and their response to immunotherapy	10
A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma	10
Lung autotransplantation for advanced central lung cancer after neoadjuvant immuno-chemotherapy: a case series study	10
Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021	10
Prognostic value of ground-glass opacity on computed tomography for patients with pathological stage IA3 lung adenocarcinoma: a multicenter retrospective cohort study	10
How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review	10
Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study	10
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer	10
EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates	10
Long-term survival after combination therapy with atezolizumab in a patient with small-cell lung cancer: a case report	10
GPRC5A is a potential prognostic biomarker and correlates with immune cell infiltration in non-small cell lung cancer	10

The clinical characteristics, treatments and prognosis of post-esophagectomy airway fistula: a multicenter cohort study	10
Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1	10
Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer	9
Dose and fractionation schedules in radiotherapy for non-small cell lung cancer	9
Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab	9
Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1+ or ALK+ non-small cell lung cancer to crizotinib therapy	9
Predicting survival in small cell lung cancer patients undergoing various treatments: a machine learning approach	9
Circ_0087378 intensifies the malignant behavior of non-small cell lung cancer cells in vitro by facilitating DDR1 via sponging miR-199a-5p	9
Multidisciplinary management of N2 stage III non-small cell lung cancer: opportunities and challenges for radiation oncology	9
Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients	9
Macrophages-based immune-related risk score model for relapse prediction in stage I–III non-small cell lung cancer assessed by multiplex immunofluorescence	9
Risk-based prediction model for selecting eligible population for lung cancer screening among ever smokers in Korea	9
Prognostic significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in second-line immunotherapy for patients with non-small cell lung cancer	9
The clinico-pathological characteristics of surgically treated young women with NSCLC	9
Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer	9
Persistent and novel changes in plasma microRNA profiles in patients with non-small cell lung cancer following tumour resection	9
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a	9
Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice?	9
The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential b	9
The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy	9
Short-term peri- and intra-tumoral CT radiomics to predict immunotherapy response in advanced non-small cell lung cancer	9
Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer	9
Prognostic implications of cellular senescence in resected non-small cell lung cancer	9
A better option for localization of multiple pulmonary nodules in the ipsilateral lung: electromagnetic navigation bronchoscopy-guided preoperative localization	9
Metachronous development of L858R and T790M EGFR mutations following ALK inhibitor therapy in stage IV lung adenocarcinoma: a case report	9
Rhabdomyolysis in a patient with advanced lung cancer treated with osimertinib: a case report	9
Patterns and outcome of unplanned care in lung cancer patients: an observational study in a medical oncology department	8
Does subtyping of high-grade pulmonary neuroendocrine carcinomas have an impact on therapy selection?	8
Circulating tumor cell methylation profiles reveal the classification and evolution of non-small cell lung cancer	8
A simple and safe surgical technique for nonpalpable lung tumors: One-stop Solution for a nonpalpable lung tumor, Marking, Resection, and Confirmation of the surgical margin in a Hybrid operating room	8
Revisiting the impact of clinicopathologic characteristics in PD-L1 profile in a large cohort of non-small cell lung cancer	8
ATM—the gene at the moment in non-small cell lung cancer	8
Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?	8
Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to predict early response to anti-tumor therapy in advanced non-small cell lung cancer (NSCLC): a comparison of intravoxel incoherent moti	8
Immunotherapy: remember the host	8
Comparison of operation time, efficacy and safety between through-the-scope stent and over-the-while stent in malignant central airway obstruction: a multi-center randomized control trial	8
KMT2C expression and DNA homologous recombination repair factors in lung cancers with a high-grade fetal adenocarcinoma component	8
The role of laboratory tests as a prognostic marker for immune-checkpoint therapy in non-small cell lung cancer	8
Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial	8
The person behind the nodule: a narrative review of the psychological impact of lung cancer screening	8
From expert recommendations to multidisciplinary team decisions: a way to set out the novel perioperative options for patients with non-small-cell lung cancer	8
Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence	8
PD-L1 mRNA derived from tumor-educated platelets as a potential immunotherapy biomarker in non-small cell lung cancer	8
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer	8
The role of RASA2 in predicting radioresistance in lung cancer through regulation of p53	8
TTF-1 and immune checkpoint therapy in non-small cell lung cancer	8
KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer	8
Single nucleotide polymorphisms in FOXP1 and RORA of the lymphocyte activation-related pathway affect survival of lung cancer patients	8
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk	8
Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapy	8
Robot-assisted minimally invasive bronchial resection with primary anastomosis for schwannoma arising from left main bronchus: a case report	8
Tarlatamab: the promising immunotherapy on its way from the lab to the clinic	8
EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAFV600E mutation: a multi-center real-world experience in China	8
Value of 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the differential diagnosis of sarcoidosis and lung cancer with lymph node metastasis: a retrospectiv	8
A cross-trait study of lung cancer and its related respiratory diseases based on large-scale exome sequencing population	8
Orthopedia homeobox protein (OTP) in the diagnostic and prognostic workup of pulmonary carcinoid tumors	7
Therapy option for early-stage lung cancer in nonsurgical patients	7
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done	7
Omission of staging PET/CT linked to reduced survival in stage III non-small cell lung cancer: insights from the LUCAS project real-world data	7
A narrative review of the migration and invasion features of non-small cell lung cancer cells upon xenobiotic exposure: insights from in vitro studies	7
Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?	7
Development of an AI model for predicting hypoxia status and prognosis in non-small cell lung cancer using multi-modal data	7
Discrepancies in PD-L1 expression, lymphocyte infiltration, and tumor mutational burden in non-small cell lung cancer and matched brain metastases	7
The opportunities and challenges of perioperative therapy of localized non-small cell lung cancer—thoughts from the KEYNOTE-671 trial	7
Performance of deep learning model and radiomics model for preoperative prediction of spread through air spaces in the surgically resected lung adenocarcinoma: a two-center comparative study	7
Bronchoscopic deployment and implantation of Diffusing alpha-emitters Radiation Therapy into the lung and mediastinum for treatment of lung cancer: a pre-clinical safety and feasibility study	7
Efficacy of ALK inhibitors in Asian patients with ALK inhibitor-naïve advanced ALK-positive non-small cell lung cancer: a systematic review and network meta-analysis	7
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung c	7
miR-16-5p specifically inhibits IFN-γ-regulated memory T helper cell differentiation in malignant pleural effusion of non-small cell lung cancer	7
Perioperative and oncological outcomes of uniportal versus three-port thoracoscopic segmentectomy for lung cancer: a propensity score matching analysis	7
Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with BRAFV600E mutation-positive metastatic non-small cell lung cancer	7
Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients	7
Can circulating tumor DNA guide treatment de-escalation in metastatic lung adenocarcinoma harboring actionable genomic alterations?	7
Targeting lung cancer brain metastases: a narrative review of emerging insights for anaplastic lymphoma kinase (ALK)-positive disease	7
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts	7
Efficacy and prognostic factors of stereotactic body radiotherapy combined with immunotherapy for pulmonary oligometastases: a preliminary retrospective cohort study	7
Immunohistochemistry identifies E-cadherin, N-cadherin and focal adhesion kinase (FAK) as predictors of stage I non-small cell lung carcinoma spread through the air spaces (STAS), and the combinations	7
Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited	7
Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration	7
Prediction of early lung adenocarcinoma spread through air spaces by machine learning radiomics: a cross-center cohort study	7
A potential central nervous system niche for trastuzumab deruxtecan in patients with HER2-expressing non-small cell lung cancer	7
Mapping the evolution and frontiers of Translational Lung Cancer Research: a bibliometric analysis and literature review	7
The predictive accuracy of CT radiomics combined with machine learning in predicting the invasiveness of small nodular lung adenocarcinoma	7
Watershed analysis of the target pulmonary artery for real-time localization of non-palpable pulmonary nodules	6
Impact of docetaxel plus ramucirumab therapy on interstitial lung disease in recurrent advanced non-small cell lung cancer patients	6
Predictive value of perioperative carcinoembryonic antigen changes for recurrence in non-small cell lung cancer	6
Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer	6
Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma	6
Real-world data on severe lung cancer: a multicenter retrospective study	6
TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemorad	6
Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk	6
Ion robotic bronchoscopy laser ablation and Da Vinci robotic segmentectomy for bilateral pulmonary nodules: a case report	6
Esophagomediastinal fistula during durvalumab plus tremelimumab with chemotherapy in angiotensin-converting enzyme 2-positive non-small cell lung cancer: a case report	6
Prophylactic cranial irradiation in SCLC	6
Clinical application of three-dimensional reconstruction in anatomical analysis of the right anterior, lateral, and posterior basal segments (RS8, RS9, and RS10) for RS9 segmentectomy	6